KLAC
56
-3
MRK
53
3
BBY
59
7
GE
85
3
ECL
69
-3
EA
44
-2
BF.B
57
7
RIG
35
-3
TSCO
55
-2
CCI
36
-5
TJX
50
2
THC
61
3
MA
65
-4
BLK
69
2
LMT
40
-5
UNP
48
-2
EBAY
50
-3
HPQ
62
2
VRTX
56
-4
PEP
50
-4
KLAC
56
-3
MRK
53
3
BBY
59
7
GE
85
3
ECL
69
-3
EA
44
-2
BF.B
57
7
RIG
35
-3
TSCO
55
-2
CCI
36
-5
TJX
50
2
THC
61
3
MA
65
-4
BLK
69
2
LMT
40
-5
UNP
48
-2
EBAY
50
-3
HPQ
62
2
VRTX
56
-4
PEP
50
-4
Financhill
Back

BridgeBio Pharma Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39

BBIO
BridgeBio Pharma

Last Price:
26.81
Seasonality Move:
21.04%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 32.5% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $25.96. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 32.5% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
39
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • The current trend is relatively stagnant and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
44.32
52-Week Low:
21.62

Prediction Charts

Market Cap:
4.88B
Price in USD:
25.96
Volume:
1.47M
Beta:
1.06

Technical Analysis

SMA50:
26.49
SMA100:
26.91
SMA200:
30.04
52-Wk Change:
-9.04%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 25.96 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 25.10 24.62 25.58 24.52
Aug-30 26.00 27.87 28.26 25.85
Sep-3 28.30 28.74 30.95 27.80
Sep-4 28.97 30.67 30.77 28.69
Sep-5 30.96 31.31 32.06 30.46
Sep-6 31.38 30.73 32.05 29.72
Sep-9 30.81 30.70 31.14 30.02
Sep-10 30.85 29.99 30.87 29.60
Sep-11 29.13 27.99 29.52 27.89
Sep-12 27.81 26.95 28.13 26.92
Sep-13 27.11 26.18 27.32 25.92
Sep-16 26.07 26.19 26.94 25.92
Sep-17 26.95 26.73 27.68 26.25
Sep-18 26.44 25.96 26.84 25.80

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $1.24 per share, and a decrease next year of $1.28 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.